ACN - Company News

Press Releases


Friday, December 23, 2022

全球主要医疗器械制造商业聚医疗集团之股份于香港联交所主板挂牌上市
专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」）的股份今天于香港联合交易所有限公司（「香港联交所」）主板正式挂牌买卖，股份代号为6929。 more info >>

全球主要醫療器械製造商業聚醫療集團之股份於香港聯交所主板掛牌上市
專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」）的股份今天於香港聯合交易所有限公司（「香港聯交所」）主板正式掛牌買賣，股份代號為6929。 more info >>

Shares of Major Global Medical Device Manufacturer OrbusNeich Medical Group Commence Trading on the Main Board of The Stock Exchange of Hong Kong
Shares of OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, today commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX"), under the stock code 6929. more info >>

Tuesday, December 13, 2022

全球主要医疗器械制造商业聚医疗集团公布在香港联交所主板上市计划详情
专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」）今日公布在香港联合交易所有限公司（「香港联交所」）主板上市计划的详情。 more info >>

全球主要醫療器械製造商業聚醫療集團公佈在香港聯交所主板上市計劃詳情
專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」）今日公佈在香港聯合交易所有限公司（「香港聯交所」）主板上市計劃的詳情。 more info >>

Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX
OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"), a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures, has today announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX"). more info >>


1 2 3 4

Latest Press Releases

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully May 28, 2025 23:29 HKT/SGT

Global Leaders Gather for XIII International Meeting on International Cooperation May 28, 2025 21:30: JST

Modern Dental Group's Thai Subsidiary Hexa Ceram Held 30th Anniversary Celebration and Dental Symposium May 28, 2025 21:30 HKT/SGT

Asia Summit on Global Health and Hong Kong International Medical and Healthcare Fair Wrap Up Successfully May 28, 2025 20:57: JST

Global Leaders Gather for XIII International Meeting on International Cooperation May 28, 2025 20:30 HKT/SGT

SAPPE Makes a Global Splash in the Beverage Market, Unveils Global Campaign "Life's too Short, You Gotta Chew" at THAIFEX - ANUGA ASIA 2025 May 28, 2025 18:00 HKT/SGT

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China May 28, 2025 17:45 JST

現代牙科集團泰國公司Hexa Ceram舉辦三十周年慶典暨牙科論壇 May 28, 2025 16:30 HKT/SGT

现代牙科集团泰国公司Hexa Ceram举办三十周年庆典暨牙科论坛 May 28, 2025 16:12 HKT/SGT

三菱重工、2024事業計画推進状況について発表 May 28, 2025 16:05: JST

GK Software becomes a Fujitsu company May 28, 2025 15:33 JST

GMG Announces Internal G(R) Lubricant Testing Results Showing 10% Fuel Savings and 33% Reduction in Particulate Emissions May 28, 2025 08:29 HKT/SGT

Spotlight: Sunny Nandwani, Founder & CEO, Acuver Consulting Inc. May 27, 2025 22:30 HKT/SGT

聯想控股旗下君聯資本及聯想之星共同投資企業派格生物醫藥在港交所成功上市 May 27, 2025 22:10 HKT/SGT

联想控股旗下君联资本及联想之星共同投资企业派格生物医药在港交所成功上市 May 27, 2025 21:41 HKT/SGT


More News >>


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575